Gianpaolo Pozzato on Advancing Hemostasis Automation Through HemoCell and Axonlab Collaboration
Gianpaolo Pozzato, EEMEA Hemostasis Product Manager, shared on LinkedIn:
”Kicked off 2026 with a focused visit to Basel, Switzerland, returning to our HemoCell installation to further optimize performance and resilience.
Why the Werfen dedicated, specialized automation matters in Hemostasis:
– Consistent, standardized workflows
– Reliable TAT even at peak load
– Strong QC, full traceability, and smart reflex testing
This trip was about aligning system capabilities with the evolving complexity of Hemostasis workloads, and translating user feedback into measurable operational gains.
Grateful to Daria Prokudina, MD for the expert on‑site support, and to our Partner Axonlab international for the excellent collaboration and hospitality.
Together we keep raising the bar for patient‑centric diagnostics.”
Stay updated with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025